the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
November 05, 2017 – The commercial names are creative, no doubt, and we like particularly “Black Gorilla”. However, time and time again, health authorities all over have to issue foreign product alerts, warning consumers, patients, and the public at large about …
Black Gorilla, Big N Hard, Rize N Shine, and the likes: Fraudulent health business Read more »
November 01, 2017 – According to the watch list of the American Food & Drug Administration (FDA) for drugs with possible safety issues from January to March 2016, the FDA was looking at the possible link between various drugs in the phosphodiesterase-5 …
Is there a risk of melanoma with erectile dysfunction drugs? Read more »
February 20, 2017 – Finasteride, is a medication used for the treatment of benign prostatic hyperplasia (on the market as Proscar (5mg) since 1992 for this indication) and male pattern hair loss (on the market as Propecia (1mg) since 1997 for this indication). Finasteride is a type II and type III 5α-reductase inhibitor, 5α-reductase …
The Post Finasteride Syndrome (PFS): Are young men left alone until up to suicide? Read more »
September 22, 2016 – The pharmacologically active compound known as sildenafil is largely used to treat erectile dysfunction (on the market for this indication under the trade name Viagra) and pulmonary arterial hypertension (on the market for this indication under the trade name Revatio) in …
January 21, 2016 – This is a never ending story. The present notification by the The American Food and Drug Administration (FDA) is once more to inform the public of a growing trend of dietary supplements or conventional foods with hidden …
Wonder-Erect Male Pills: No wonder they contain hidden drug ingredient vardenafil Read more »
June 5, 2015 – This is an edited post based on a PRNewswire release (see here) which refers to the 2015 June 4th joint meeting of the U.S. Food and Drug Administration’s (FDA) joint meeting of the Bone, Reproductive and Urologic Drugs Advisory …